BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37639817)

  • 21. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G; Diedrich K; Devroey P; Kolibianakis EM
    Hum Reprod Update; 2006; 12(2):159-68. PubMed ID: 16254001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.
    Haas J; Bassil R; Samara N; Zilberberg E; Mehta C; Orvieto R; Casper RF
    Hum Reprod; 2020 Jul; 35(7):1648-1654. PubMed ID: 32563188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
    Georgiou EX; Melo P; Baker PE; Sallam HN; Arici A; Garcia-Velasco JA; Abou-Setta AM; Becker C; Granne IE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31747470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
    Qiu Q; Huang J; Li Y; Chen X; Lin H; Li L; Yang D; Wang W; Zhang Q
    Hum Reprod; 2020 Jun; 35(6):1411-1420. PubMed ID: 32383771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
    Youssef MA; Abou-Setta AM; Lam WS
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
    Abdulkhalikova D; Bokal EV; Stimpfel M; Ciglar P; Korosec S
    Front Endocrinol (Lausanne); 2022; 13():826411. PubMed ID: 35464066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles.
    Zhang J; Wang Y; Mao X; Chen Q; Hong Q; Cai R; Zhang S; Kuang Y
    Reprod Biomed Online; 2017 Dec; 35(6):701-707. PubMed ID: 28993105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 31. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial.
    Santos-Ribeiro S; Mackens S; Popovic-Todorovic B; Racca A; Polyzos NP; Van Landuyt L; Drakopoulos P; de Vos M; Tournaye H; Blockeel C
    Hum Reprod; 2020 Dec; 35(12):2808-2818. PubMed ID: 32964939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders.
    Tulek F; Kahraman A; Demirel LC
    Gynecol Endocrinol; 2022 Sep; 38(9):731-735. PubMed ID: 35856433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does 'Dual Trigger' Increase Oocyte Maturation Rate?
    Ben-Haroush A; Sapir O; Salman L; Altman E; Garor R; Margalit T; Shufaro Y; Oron G
    J Obstet Gynaecol; 2020 Aug; 40(6):860-862. PubMed ID: 31790320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles.
    Oliveira CM; Oliveira CAM; Fonseca LL; Souza KRR; Radaelli MRM
    JBRA Assist Reprod; 2021 Apr; 25(2):246-251. PubMed ID: 33507721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials.
    Hu KL; Wang S; Ye X; Zhang D; Hunt S
    Reprod Biol Endocrinol; 2021 Jun; 19(1):78. PubMed ID: 34059045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Trigger for Final Follicular Maturation Improves Cumulative Live-Birth Rate in Ovarian Stimulation for Freeze-All
    Zhu H; Zhao C; Pan Y; Zhou H; Jin X; Xu W; Zhang S
    Front Endocrinol (Lausanne); 2021; 12():708247. PubMed ID: 34349729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.
    Chen Y; Zhang Y; Hu M; Liu X; Qi H
    Gynecol Endocrinol; 2014 Jun; 30(6):431-7. PubMed ID: 24731070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.